Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed the day trading at $7.37 up 0.96% from the previous closing price of $7.30. In other words, the price has increased by $0.96 from its previous closing price. On the day, 1.45 million shares were traded. MRVI stock price reached its highest trading level at $7.51 during the session, while it also had its lowest trading level at $7.26.
Ratios:
For a better understanding of MRVI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.07. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 8.00. In the meantime, Its Debt-to-Equity ratio is 1.47 whereas as Long-Term Debt/Eq ratio is at 1.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on April 10, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On December 12, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral and also lowered its target price recommendation from $10 to $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1852817920 and an Enterprise Value of 1374968704. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.37 while its Price-to-Book (P/B) ratio in mrq is 2.34. Its current Enterprise Value per Revenue stands at 4.759 whereas that against EBITDA is 86.552.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $16.62, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is -1.66%, while the 200-Day Moving Average is calculated to be -8.44%.
Shares Statistics:
Over the past 3-months, MRVI traded about 2.77M shares per day on average, while over the past 10 days, MRVI traded about 1639710 shares per day. A total of 132.23M shares are outstanding, with a floating share count of 106.83M. Insiders hold about 19.26% of the company’s shares, while institutions hold 85.66% stake in the company. Shares short for MRVI as of 1711584000 were 5120876 with a Short Ratio of 1.85, compared to 1709164800 on 6196931. Therefore, it implies a Short% of Shares Outstanding of 5120876 and a Short% of Float of 4.64.
Earnings Estimates
Investors are eagerly awaiting the insights provided by Marvell Technology, Inc. analysts currently analyzing and rating the stock of Maravai LifeSciences Holdings Inc (MRVI).The consensus estimate for the next quarter is $2.09, with high estimates of $2.94 and low estimates of $7.37.
